期刊文献+

小鼠TNF-α基因RNAi慢病毒载体的构建及体外研究 被引量:1

Construction of lentivector-mediated RNAi and it efficiently downregulates expression of murine TNF-α gene in vitro
原文传递
导出
摘要 目的为探讨TNF-α在C型Niemann-Pick病(NPC)神经变性中的作用,构建携带小鼠TNF-α-si RNA的慢病毒载体并进行体外研究。方法设计3个TNF-α-si RNA序列和1个无关对照序列,克隆到酶切的pSI H1-H1-copGFP si RNA载体;重组质粒转染293T细胞,通过实时定量PCR检测筛选出干扰效果最佳的TNF-α-si RNA;筛选出的pSI H-si RNA、pSI H-negative分别与慢病毒包装质粒共转染293T细胞生成慢病毒;慢病毒感染BV-2细胞和星形胶质细胞,采用RT-PCR以及Elisa检测TNF-α-si RNA的沉默效果。结果成功构建携带TNF-α-si RNA的慢病毒载体,滴度达2×108ifu/L;慢病毒感染BV-2和星形胶质细胞,表达GFP且可下调TNF-α表达。结论TNF-α-si RNA能明显下调TNF-α的表达,为研究和治疗神经变性疾病以及TNF-α相关疾病提供了有力的工具。 Objective To study the function of TNF-α in Niemann-Pick type C diseases, and to use lentiviral-delivered RNA interference (RNAi) to silenceexpression of murine TNF-α gene invitro. Methods Three TNF-α-siRNA of mouse and a negative sequence were designed and cloned into linearized pSIH1-HI-copGFP siRNA Vector. Above recombinants were transfected by lipofectamine into 293T cells. The gene silencing efficacy of the 3 targets was compared by realtime PCR. The optimized pSIH1- TNF-msiRNA2 and pSIH-negative were co-transfected into 293T cells with the TNF-α-siRNA was determined by RT-PCR in BV-2 cells and astrocytes. Results Successfully constructed Lentivector-mediated -siRNA , and the tite is 2 × 10^8 ifu/L. RNAi efficiently down regulated expression of murine TNF-α gene invitro. Conclusions TNF-α-siRNA down regulated expression of TNF-α gene in vitro, this may provide a potential tool for studying and treating Neurodegen erative diseases and TNF-α-related diseases.
出处 《卒中与神经疾病》 2009年第1期3-6,共4页 Stroke and Nervous Diseases
基金 国家自然科学基金资助(No.30670735 NO.30670737)
关键词 慢病毒载体 TNF-α 神经系统变性疾病 RNA干扰 Lentiviral vector TNF-α Neurodegenerative disease RNA interference
  • 相关文献

参考文献14

  • 1张宇红,卜碧涛,方思羽,李江林,曹小丽,许康,占克斌.C型Niemann-Pick病小鼠P27^(kipl)表达异常与神经元变性和星形胶质细胞增生[J].卒中与神经疾病,2004,11(3):131-135. 被引量:7
  • 2Wu YP, Mizukami H, Matsuda J, et al. Apoptosis accompanied by up-regulation of TNF alpha death pathway genes in the brain of Niemann-Pick type C disease, Mol Genet Metab, 2005, 84 (1) :9-17.
  • 3P. Bezzi, M. Domercq, L. Brambilla, et al. CXCR4-activated astro- cyte glutamate release via TNF-alpha: amplification by microglia trig-gers neurotoxicity. Nat Neurosci, 2001,4(7) :702-7|0.
  • 4Tobinick E. Perispinal etanercept for treatment of Alzheimer's disease. Curr Alzheimer Res, 2007,4(5):550-552.
  • 5Butovsky O, Koronyo-Hamaoui M, Kunis G, et al. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic- like microglia expressing insulin-like growth factor 1. Proe Natl Acad Sci USA, 2006,103 (31 ) :11784-11789.
  • 6Nelson TJ, Alkon DL. Oxidation of cholesterol by amyloid precursor protein and beta amyloid peptide. J Biol Chem, 2005,280 (8) : 7377-7387.
  • 7Takeuehi H, Jin S, Wang J, et al. Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem, 2006, 281 (30) : 21362-21368.
  • 8Culbert AA, Skaper SD, Howlett DR, et al. MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease. J Biol Chem, 2006,281 (33) :23658-23667.
  • 9Li R, Yang L, Lindholm K, et al. Tumor necrosis factor death receptor signaling cascade is required for amyloid-beta protein-induced neuron death. J Neurosci, 2004,24(7) : 1760-1771.
  • 10Alvarez A, Cacabelos R, Sanpedro C, et al. Serum TNF-a levels are increased and correlate negatively with free IGF-I in Alzheimer disease. Neurobiol Aging, 2007,28(4):533-536.

二级参考文献11

  • 1Ridet JL, Malhotra SK, Privat A, et al.Reactive astrocytes: cellular and molecular cues to biological function.TINS, 1997, 20(12): 570-577.
  • 2Bu B, Jin Li, Davies P, et al.Deregulation of cdk5, Hyperphosphorylation, and Cytoskeletal Pathology in the Niemann-Pick Type C Murine Model.Journal of Neuroscience, 2002, 22(15): 6515-6525
  • 3Vincent I, Bu B, Hudson K, et al.Constitutive Cdc25B tyrosine phosphatase activity in adult brain neurons with M phase-type alterations in Alzheimer's disease.Neuroscience, 2001, 105(3): 639-650.
  • 4Loftus SK, Morris JA, Carstea ED, et al.Murine model of Niemann-Pick C disease: mutation in a cholesterolhomeostasis gene.Science, 1997, 277(5323): 232-235.
  • 5Kawamata N, Morosetti S, Miller CW, et al.Molecular analysis of the cyclin-dependent kinase inhibitor gene P27kipl in human malignancies.Cancer Res, 1995, 55(8): 2266-2269.
  • 6Kawana H,Tamaru J,Tanaka T,et al.Role of P27kipl and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer.American Journal of Pathol, 1998, 153(2): 505-513.
  • 7Kiyokawa H,Kineman RD,Manova-Todaova KD,et al.Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of P27kipl.Cell, 1996, 85(5): 721-732.
  • 8Liang CL, Song T, Yazdani U, et al.Neurodegeneration in the Niemann-Pick C mouse: glial involvement.German DC.Neuroscience, 2002, 109(3): 437-450.
  • 9Shambaugh GE, Haines GK, Koch A, et al.Immunohistochemical examination of the INK4 and Cip inhibitors in the rat neonatal cerebellum: cellular localization and the impact of protein calorie malnutrition.Brain Res, 2000, 855(1): 11-22.
  • 10Vincent I, Jicha G, Rosado M, et al.Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain.J Neurosci, 1997, 17(10): 3588-3598.

共引文献6

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部